Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Scholar Rock Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11322
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock Holding Corp, is a biopharmaceutical company that discovers and develops novel medicines for serious unmet medical needs. Its proprietary technology platform develops new medicines, modulating supracellular activation, for the application in the treatment of fibrosis, diseases of musculoskeletal systems, and autoimmune diseases. Scholar Rock’s lead product candidate include SRK-015, a selective inhibitor which activates latent myostatin in skeletal muscle used for the treatment of spinal muscular atrophy (SMA). The company is creating a pipeline of novel product candidates for a wide range of serious diseases such as neuromuscular disorders, cancer, fibrosis, and anemia. It collaborates with various biotechnology companies for the development of its pipeline products. Scholar Rock is headquartered in Cambridge, Massachusetts, the US.

Scholar Rock Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Scholar Rock Raises USD47 Million in Series C Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 12
Scholar Rock Raises USD20 Million in Series A Venture Financing 14
Partnerships 16
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 16
Licensing Agreements 17
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 17
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 18
Scholar Rock Inc – Key Competitors 19
Scholar Rock Inc – Key Employees 20
Scholar Rock Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Aug 08, 2018: Scholar Rock reports second quarter 2018 financial results and updates on business progress 22
Corporate Communications 24
Apr 09, 2018: Scholar Rock Appoints Rhonda Chicko as Chief Financial Officer 24
Jul 06, 2017: Scholar Rock Appoints David L. Hallal as Chairman of Board of Directors 25
May 23, 2017: Scholar Rock Announces Drug Development Leaders, Michael Gilman and Shelia Violette, to Join Scientific Advisory Board 26
Product News 28
01/23/2018: Scholar Rock and Collaborators at Harvard Medical School and Northeastern University Elucidate Molecular Basis of Myostatin Activation – a Key Physiological Process in Muscle Health 28
Clinical Trials 29
Jul 10, 2017: Scholar Rock and the Miami Project to Cure Paralysis Present Preclinical Data Demonstrating Therapeutic Potential of SRK-015 in Spinal Cord Injury at 35th Annual National Neurotrauma Symposium 29
Jun 28, 2017: Scholar Rock to Develop SRK-015 to Improve Muscle Function in Patients with Spinal Muscular Atrophy 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Scholar Rock Inc, Pharmaceuticals & Healthcare, Key Facts 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Scholar Rock Raises USD47 Million in Series C Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 12
Scholar Rock Raises USD20 Million in Series A Venture Financing 14
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 16
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 17
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 18
Scholar Rock Inc, Key Competitors 19
Scholar Rock Inc, Key Employees 20

List of Figures
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Scholar Rock Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quaker Chemical Corp (KWR):企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Chiesi Farmaceutici SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, …
  • Shanghai Electric Group Co Ltd:企業の戦略・SWOT・財務情報
    Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Imprimis Pharmaceuticals Inc (IMMY):製薬・医療:M&Aディール及び事業提携情報
    Summary Imprimis Pharmaceuticals Inc (Imprimis), formerly Transdel Pharmaceuticals Inc., focuses on the development and commercialization of proprietary drug formulations in the therapeutic areas of urology and ophthalmology. The company by utilizing its SSP Technology develops injectable Dropless T …
  • Nestle Health Science SA:医療機器:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Omnicom Group, Inc.:企業の戦略・SWOT・財務情報
    Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Omnicom Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CorMatrix Cardiovascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary CorMatrix Cardiovascular Inc (CorMatrix) is a medical device company that offers biomaterial devices. The company’s products comprise interim bioscaffolds, cardiovascular devices, biomaterials, cardiovascular medical devices, extracellular matrix materials, cardiovascular surgery devices, cr …
  • Attijari Bank SA:企業の戦略・SWOT・財務分析
    Attijari Bank SA - Strategy, SWOT and Corporate Finance Report Summary Attijari Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pall Corp-医療機器分野:企業M&A・提携分析
    Summary Pall Corp (Pall), a subsidiary of Danaher Corporation, is a supplier of filtration, separation and purification products and technologies to remove solid, liquid and gaseous contaminants from liquids and gases. Its major products include biochemicals, bioreactors, breathers, canisters, cartr …
  • MidAmerican Energy Co:電力:M&Aディール及び事業提携情報
    Summary MidAmerican Energy Company (MidAmerican Energy), a subsidiary of Berkshire Hathaway Energy, is a regulated electric and natural gas utility company that carries out the generation, transmission and distribution and selling of electricity. The company also undertakes distribution, selling and …
  • Almirall S.A.:企業の戦略・SWOT・財務分析
    Almirall S.A. - Strategy, SWOT and Corporate Finance Report Summary Almirall S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析
    Summary Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutic …
  • Suzlon Energy Limited:企業の戦略・SWOT・財務情報
    Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ShaMaran Petroleum Corp (SNM):石油・ガス:M&Aディール及び事業提携情報
    Summary ShaMaran Petroleum Corp (ShaMaran Petroleum), formerly Bayou Bend Petroleum Ltd is an independent oil and gas exploration and development company. The corporation explores, produces, and develops oil and gas assets. It holds interests and operates Atrush petroleum property located in Kurdist …
  • Crescita Therapeutics Inc (CTX):企業の財務・戦略的SWOT分析
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • Oncgnostics GmbH:企業の製品パイプライン分析
    Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that offers development of in-vitro diagnostic tests for the therapeutics area of cancer. The company offers pipeline products such as GynTect technology a system based on the detection of epigenetic biomarkers mainly in the me …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Raytheon Technologies Corp (RTX):企業の財務・戦略的SWOT分析
    Raytheon Technologies Corp (RTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PTT Public Co Ltd (PTT)-石油・ガス分野:企業M&A・提携分析
    Summary PTT Public Company Limited (PTT) is an integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, tr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆